Jorge Conde

Actively Investing

Andreessen Horowitz

General Partner at a16z Bio + Health

San Francisco, CAWebsite

Investment Thesis

Invests in companies at the convergence of biology and technology. Focuses on computational biology, digital health, and bio platforms using engineering and data science approaches to transform healthcare.

About

General Partner at Andreessen Horowitz leading the Bio + Health fund. Former VP at Syros Pharmaceuticals and CEO of Enrolled (acquired). Genome scientist by training who bridges biology and technology investing.

Sectors of Interest

Bio + Health

Computational Biology

Digital Health

Drug Discovery

Diagnostics

Jorge Conde

Investment Thesis

About

Sectors of Interest

Portfolio

Investment Details

Connect with Jorge Conde